Marco Licciardello

Title: Marco Licciardello: Innovator in Cancer Therapy

Introduction

Marco Licciardello is a prominent inventor based in London, GB. He has made significant contributions to the field of cancer therapy, particularly in the treatment of androgen receptor positive cancers. His innovative approach combines antiandrogens with other therapeutic agents to enhance treatment efficacy.

Latest Patents

Marco Licciardello holds 1 patent for his invention titled "Combination of an antiandrogen with a vitamin K antagonist or with a gamma-glutamyl carboxylase inhibitor for the therapy of androgen receptor positive cancer." This patent addresses the combination of an antiandrogen with a vitamin K antagonist or a gamma-glutamyl carboxylase inhibitor for the treatment or prevention of androgen receptor positive cancers, such as prostate cancer. The invention also focuses on resensitizing antiandrogen-resistant prostate cancer to antiandrogen treatment, providing a pharmaceutical composition that includes these components along with a pharmaceutically acceptable excipient.

Career Highlights

Marco Licciardello is associated with Cemm Forschungszentrum Fur Molekulare Medizin GmbH, where he continues to advance his research in molecular medicine. His work is pivotal in developing new therapeutic strategies for cancer treatment.

Collaborations

Marco collaborates with notable professionals in his field, including his coworker Stefan Kubicek. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Marco Licciardello's contributions to cancer therapy through his innovative patent demonstrate his commitment to improving treatment options for patients with androgen receptor positive cancers. His work continues to inspire advancements in the medical field.